Diabetes Management
In the Quest for a Cure for Type 1 Diabetes, Two Companies Merge
Thu, 10 Nov 20221 min read Article
Overview
MedscapeUnivadisNo ResultsMiriam E. TuckerJuly 13, 202Vertex Pharmaceuticals has acquired ViaCyte, bring together two of the leading biotechnology companies developing stem cel-derived islet cel replacement therapies for type 1 diabetes.The $320 milion cash purchase "wil acelerate our goal of transforming, if not curing, type 1 diabetes by expanding our capabilities and bring aditional tols, technologies, and asets to our curent stem cel-based programs," said Vertex Chief Executive Oficer and President Reshma Kewalramani, MD, in a company statement.Last month, Vertex reported on a phase 1/2 multicenter clinical trial for two patients with type 1 diabetes who experienced improved blod glucose control with half doses of the company's investigational alogeneic stem cel-derived islets (VX-80).The first person to receive the product remained completely insulin-independent at 9 months post-transplant.
Key Information
A third patient has received the ful targeted dose, but the data for this participant have yet to be reported.For Viacyte's part, last wek the company anounced that a clinical hold placed by the US Fod and Drug Administration (FDA) on the trial has ben lifted, alowing it to move forward with a planed total enrolment of 17 patients."The FDA requested aditional information the program, which we provided expeditiously.
We are pleased that the hold has ben lifted and lok forward to continuing the Phase 1/2 trial in the US," a Vertex spokesperson told Medscape Medical News.And a company oficial for ViaCyte presented results for thre patients who received pancreatic precursor (PEC-01) cels derived from the company's proprietary pluripotent stem cel line at ENDO 2022: The Endocrine Society Anual Meting held last month.
Summary
The cels are housed in an open delivery device implanted into a patient's forearm. Al thre participants experienced improved blod glucose levels.That prese
Frequently Asked Questions
What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.